0.37 (-%)
As of Dec 06, 2024
Source:
IGC Pharma, a clinical-stage company developing treatments for Alzheimer’s disease, is committed to transforming patient care by offering faster-acting and more effective solutions. Our lead drug, IGC-AD1, embodies this vision by tackling a critical challenge – managing agitation in Alzheimer’s dementia.
Country | United States |
Headquarters | potomac, maryland |
Phone Number | (301) 983-0998 |
Industry | manufacturing |
CEO | Ram Mukunda |
Website | www.igcpharma.com |